COMMUNIQUÉS West-GlobeNewswire

The Joint Corp. to Host Conference Call on Thursday, March 8, to Discuss Fourth Quarter and Full Year 2017 Results
22/02/2018
SCOTTSDALE, Ariz., Feb. 22, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT ), a national operator, manager and franchisor of chiropractic clinics, announced it will report its fourth quarter and full year 2017 [...]
ContraVir Pharmaceuticals Announces TXL™ Has Been Granted Orphan Drug Designation for the Treatment of HBV in a Pediatric Population
22/02/2018
EDISON, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]
Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast
22/02/2018
NEW YORK, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ) a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
BioSig Technologies to Partner with Focus Marketing
22/02/2018
Santa Monica, CA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Chimerix to Announce Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018
22/02/2018
DURHAM, N.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX ), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that it [...]
Aegis Awarded Patent for Fast Acting Nasal Spray Opioid Blockers and Pain Medications
22/02/2018
SAN DIEGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 9,895,444 providing non-invasive metered nasal spray delivery of multiple opioid blockers such [...]
Hemostemix Signs Manufacturing Agreement with Aspire Health Science
22/02/2018
CALGARY, Alberta, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM) is pleased to announce it has finalized the terms of a contract manufacturing services agreement [...]
Emerald Health Therapeutics Named as #1 2018 TSX Venture 50™ Performer
22/02/2018
VICTORIA, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V: EMH ) (OTCQX:EMHTF) ("Emerald") has achieved the #1 ranking in the 2018 TSX Venture 50™ for the clean technology [...]
Scythian Biosciences Corp. Announces Ringing of the Nasdaq Stock Market Closing Bell
22/02/2018
TORONTO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTCQB:SCCYF) is pleased to announce that the Company will ring the closing bell at [...]
Amedisys-Availity Relationship Yields Faster Payor Authorizations
22/02/2018
BATON ROUGE, La., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Thanks to a new relationship with Availity, LLC (“Availity”), Amedisys, Inc. (NASDAQ: AMED ), one of the nation’s leading home health, hospice and personal care [...]
Actinium Pharmaceuticals Announces Commencement of Rights Offering Subscription Period
22/02/2018
- Subscription period expected to end on March 2, 2018 at 5:00 PM ET NEW YORK, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") , announced today that [...]
XORTX Therapeutics Appoints Dave Matthews CFO
22/02/2018
CALGARY, Alberta, Feb. 22, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney [...]
Repligen Reports Fourth Quarter 2017 Financial Results, Provides Guidance for 2018
22/02/2018
- Revenue for 2017 increased by 35% to $141.2 million (36% at constant currency) - - GAAP EPS for 2017 more than doubled to $0.72, including a positive $0.24 impact of U.S. tax reform - - Spectrum outperforms on revenue [...]
Shire Recognizes Rare Disease Day 2018 with Global Initiatives Focused on Reducing the Time to Diagnosis
22/02/2018
Shire Recognizes Rare Disease Day 2018 with Global Initiatives Focused on Reducing the Time to Diagnosis Diagnosis is one of the most important issues affecting health, longevity and well-being for rare disease patients [...]
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update
22/02/2018
XERMELO ® (telotristat ethyl) U.S. Net Sales Since March 2017 Launch Reach $15.1 Million Regulatory Filings for Sotagliflozin in Patients with Type 1 Diabetes Expected in First Quarter of 2018 THE WOODLANDS, Texas, Feb [...]
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2017 Earnings Release Date and Conference Call
22/02/2018
NASHVILLE, Tenn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that the Company will release [...]
Natus Announces $30 Million Share Repurchase Program
22/02/2018
PLEASANTON, Calif. , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) announced that its Board of Directors has authorized the repurchase of up to $30 million of the Company's common stock. [...]
DiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic Stroke
22/02/2018
DM199 may offer an effective and safe treatment with a significantly longer treatment window (24 hours) compared to the current standard of care REMEDY trial lead by prominent neurologist Dr. Bruce Campbell, its [...]
RedHill Biopharma Provides Fourth Quarter and Full-Year 2017 Investor Update
22/02/2018
Key Highlights: Top-line results from the Phase III study with RHB-104 for Crohn’s disease expected in mid-2018 Top-line results from the confirmatory Phase III study with TALICIA ® for H. pylori infection expected in [...]

Pages